Related Experiment Videos
GB virus C E2 glycoprotein: expression in CHO cells, purification and characterization
T K Surowy1, T P Leary, R J Carrick
1Experimental Biology Research, Abbott Laboratories, Dept. 90D, North Chicago, IL 60064, USA. teresa.surowy@add.ssw.abbott.com
The Journal of General Virology
|August 1, 1997
Summary
Researchers developed an ELISA to detect GB virus C (GBV-C) E2 antibodies in human sera. This assay is crucial for understanding GBV-C
Area of Science:
- Virology
- Immunology
- Biochemistry
Background:
- GB virus C (GBV-C) is a human flavivirus.
- The E2 envelope glycoprotein is a key target for host immune responses.
- Understanding GBV-C antibody prevalence is important for clinical and epidemiological studies.
Purpose of the Study:
- To produce and purify a recombinant GBV-C E2 envelope glycoprotein fragment (E2-315).
- To develop an Enzyme-Linked Immunosorbent Assay (ELISA) for detecting antibodies against GBV-C E2 in human sera.
- To investigate the nature of epitopes recognized by GBV-C E2 antibodies.
Main Methods:
- Expression and secretion of a 315 amino acid recombinant GBV-C E2 glycoprotein (E2-315) from CHO cells.
- Purification of E2-315 using affinity chromatography with a FLAG-specific monoclonal antibody.
- Characterization of purified E2-315, including molecular mass determination and N-glycosylation analysis.
- Development and validation of an ELISA using native and denatured E2-315 to detect human antibodies.
Main Results:
- Recombinant E2-315 was successfully expressed, secreted, and purified.
- The purified E2-315 protein (48-56 kDa) was confirmed to be N-glycosylated.
- The developed ELISA detected antibodies to GBV-C E2 in human sera.
- Antibody reactivity was significantly higher with native E2-315 compared to denatured E2, indicating recognition of conformational epitopes.
Conclusions:
- A functional ELISA for detecting GBV-C E2 antibodies has been developed.
- GBV-C E2 antibodies primarily target conformational epitopes.
- This assay will aid in understanding the clinical significance and epidemiology of GBV-C infections.